Dr. MacKay’s research group explores biomolecular engineering and nanomedicine. He received his S.B. in chemical engineering and biology from the Massachusetts Institute of Technology. A Howard Hughes Medical Institute Predoctoral Fellow, he completed his Ph.D. at the University of California at San Francisco and Berkeley in the joint graduate group in Bioengineering. As a Kirschstein National Research Service Award Postdoctoral Fellow, Dr. Mackay studied at Duke University in the Department of Biomedical Engineering. Dr. MacKay joined the faculty at the University of Southern California in the Departments of Pharmacology and Pharmaceutical Sciences, Biomedical Engineering, and Ophthalmology. Dr. MacKay is a full member of the USC Norris Comprehensive Cancer Center. He has authored over 64 peer-reviewed publications. Dr. MacKay is an executive editor at the journal Advanced Drug Delivery Reviews and a standing member of the NIH study section on Nanomedicine. His work has been supported by the US Army, NIH/NIGMS, NIH/NIBIB, NIH/NEI, StopCancer, USC School of Pharmacy, USC Ming Hsieh Institute, and the L.K. Whittier Foundation.